Drug Trial Radar · NCT03315143
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Last checked: Nov 20, 2026Latest source record: Oct 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
10,584
Actual
Start
Dec 19, 2017
Primary completion
Jul 8, 2020
Study completion Jul 8, 2020
Sponsor
- Lead sponsor
- Lexicon PharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- Sanofi
- First posted
- Oct 19, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study was to compare the effect of sotagliflozin to placebo on total occurrences of cardiovascular (CV) death, hospitalization for heart failure \[HHF\], and urgent visit for heart failure \[HF\] in participants with type 2 diabetes, cardiovascular risk factors, and moderate to severely impaired renal function.
Conditions
- Heart Failure
- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases
Interventions
SotagliflozinDrug
Sotagliflozin was administered as a tablet(s), orally once daily.
PlaceboDrug
Placebo was administered as a tablet(s) (identical to the sotagliflozin tablet in appearance), orally once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Total Occurrences of Cardiovascular (CV) Death, Hospitalizations for Heart Failure (HHF) and Urgent Visits for Heart Failure (HF)Time frame: Up to 30 months
Locations
754 sites in 45 countries. Site status is shown where the registry gives one.
Investigational Site Number 8400017
Birmingham, Alabama
Investigational Site Number 8400096
Sheffield, Alabama
Investigational Site Number 8400004
Mesa, Arizona
Investigational Site Number 8400059
Mesa, Arizona
Investigational Site Number 8400021
Peoria, Arizona
Investigational Site Number 8400014
Surprise, Arizona
Investigational Site Number 8400071
Little Rock, Arkansas
Investigational Site Number 8400039
Beverly Hills, California
Investigational Site Number 8400042
Concord, California
Investigational Site Number 8400089
Fresno, California
Investigational Site Number 8400006
Huntington Park, California
Investigational Site Number 8400036
Long Beach, California
Investigational Site Number 8400073
Los Angeles, California
Investigational Site Number 8400084
Los Angeles, California
Investigational Site Number 8400035
Los Gatos, California
Investigational Site Number 8400043
Northridge, California
Investigational Site Number 8400025
Sacramento, California
Investigational Site Number 8400018
San Dimas, California
Investigational Site Number 8400070
Temecula, California
Investigational Site Number 8400013
Waterbury, Connecticut
Investigational Site Number 8400095
Bradenton, Florida
Investigational Site Number 8400090
Clearwater, Florida
Investigational Site Number 8400121
Clearwater, Florida
Investigational Site Number 8400049
Cooper City, Florida
Investigational Site Number 8400092
Hialeah, Florida
Investigational Site Number 8400026
Hollywood, Florida
Investigational Site Number 8400134
Jacksonville, Florida
Investigational Site Number 8400055
Jacksonville, Florida
Investigational Site Number 8400056
Jacksonville, Florida
Investigational Site Number 8400031
Jacksonville, Florida
Investigational Site Number 8400037
Maitland, Florida
Investigational Site Number 8400078
Miami, Florida
Investigational Site Number 8400117
Miami, Florida
Investigational Site Number 8400119
Miami, Florida
Investigational Site Number 8400118
Miami, Florida
Investigational Site Number 8400105
Miami, Florida
Investigational Site Number 8400120
Miami, Florida
Investigational Site Number 8400088
North Miami Beach, Florida
Investigational Site Number 8400106
Opa-locka, Florida
Investigational Site Number 8400063
Ormond Beach, Florida
Showing 40 of 754 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.